Jefferies Financial Group Reiterates Buy Rating for ConvaTec Group (LON:CTEC)

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reiterated by stock analysts at Jefferies Financial Group in a note issued to investors on Friday,London Stock Exchange reports. They currently have a GBX 325 target price on the stock. Jefferies Financial Group’s target price indicates a potential upside of 55.80% from the company’s current price.

Several other equities research analysts have also commented on the company. Stifel Nicolaus restated a “buy” rating and set a GBX 315 price target on shares of ConvaTec Group in a research note on Wednesday, March 11th. Berenberg Bank reiterated a “buy” rating and set a GBX 340 target price on shares of ConvaTec Group in a report on Tuesday, April 21st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research report on Wednesday, April 8th. Finally, Citigroup restated an “outperform” rating and issued a GBX 315 price target on shares of ConvaTec Group in a report on Thursday, March 5th. Nine equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of GBX 319.67.

ConvaTec Group Trading Down 0.3%

Shares of CTEC traded down GBX 0.60 during trading hours on Friday, hitting GBX 208.60. The stock had a trading volume of 64,630,465 shares, compared to its average volume of 37,529,566. The company has a debt-to-equity ratio of 106.19, a quick ratio of 0.96 and a current ratio of 1.53. The firm has a market cap of £4.08 billion, a P/E ratio of 24.26, a P/E/G ratio of 0.93 and a beta of 0.78. The company’s fifty day simple moving average is GBX 224.81 and its 200 day simple moving average is GBX 232.05. ConvaTec Group has a 12-month low of GBX 199 and a 12-month high of GBX 311.20.

Insider Transactions at ConvaTec Group

In other ConvaTec Group news, insider Jonny Mason sold 291,149 shares of the firm’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of GBX 234, for a total value of £681,288.66. Corporate insiders own 0.95% of the company’s stock.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.